Shares of IDEXX Laboratories slid 5.32% to $520.65 at 14:30 EST on Tuesday, after two successive sessions in a row of gains. NASDAQ Composite is falling 2.48% to $13,550.11, after two successive sessions in a row of losses. This seems, as yet, an all-around rough trend exchanging session today.
IDEXX Laboratories’s last close was $549.88, 10.24% below its 52-week high of $573.99.
The company’s growth estimates for the present quarter and the next is 32.6% and 17.4%, respectively.
IDEXX Laboratories’s Revenue
Year-on-year quarterly revenue growth grew by 19.1%, now sitting on 2.71B for the twelve trailing months.
IDEXX Laboratories’s Stock Yearly Top and Bottom Value
IDEXX Laboratories’s stock is valued at $520.65 at 14:30 EST, below its 52-week high of $573.99 and way higher than its 52-week low of $244.98.
IDEXX Laboratories’s Moving Average
IDEXX Laboratories’s worth is higher than its 50-day moving average of $504.66 and way above its 200-day moving average of $466.99.
More news about IDEXX Laboratories.